MedPath

Lexibase

Brand Name: Lexibase

Generic Name: Cefalexin (as Monohydrate)

Active
Registration Number

DR-XY17073-B

Dosage Form

Powder For Suspension

Issuance Date

May 31, 2022

Expiry Date

July 29, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mg/5 mL
Packaging60mL Amber Glass Bottle (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Cephalosporins)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cefalexin (as Monohydrate)Active
Monograph: cefalexin (as monohydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform